The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

被引:32
作者
Cosi, C [1 ]
Koek, W [1 ]
机构
[1] Ctr Rech Pierre Fabre, Div Neurobiol 2, F-80106 Castres, France
关键词
S-35]GTP gamma S binding; 5-HT1A receptor; inverse agonist; WAY; 100635;
D O I
10.1016/S0014-2999(00)00410-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonist binding to G protein-coupled receptors induces the formation of a receptor-G protein complex and subsequent guanosine 5'-diphosphate/guanosine 5'-triphosphate (GDP/GTP) exchange. Some receptors, however, form receptor-a protein complexes and promote GDP/GTP exchange even when not occupied by agonists. Such receptors preferentially activate pertussis toxin-sensitive G proteins (i.e., G(i)/G(o)), and the interactions of receptors and G proteins are affected by monovalent cations (most notably Na+), both in the occupied and unoccupied state. We investigated the effects of Na+ on the intrinsic activity of 5-hydroxytryptamine,. (5-HT1A) receptor ligands, measured as maximal effect (E-MAX), using guanosine 5'-0-(3-[S-35]thio)-triphosphate ([S-35]GTP gamma S) binding to membranes prepared from human epithelioid carcinoma (HeLa) cells, expressing 500 fmol/mg protein of cloned human 5-HT1A receptor (HA7 cells). A decrease of the NaCl concentration decreased the maximal effect of serotonin, increased basal [S-35]GTP gamma S binding, and increased the negative intrinsic activity of spiperone and N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-N-(2-pyridinyl)cyclohexanecarboxamide (WAY 100635). This ability of WAY 100635 to decrease basal [S-35]GTP gamma S binding was antagonized by (s)-N-tert-butyl-3-(4-(2-methaxyphenyl)piperazine-1-yl)-2-phenylpropanamide ((s)-WAY 100135) (pA(2) = 7.77). Further, WAY 100635 was able to antagonize carboxamidotryptamine (5-CT)-stimulated [S-35]GTP gamma S binding with a pA(2) of 9.9, in standard NaCl conditions, and of 9.7, in the absence of NaCl. Changes in membrane concentration did not affect the ability of WAY 100635 to decrease [S-35]GTP gamma S binding. WAY 100635 did not affect basal [S-35]GTP gamma S binding to membranes from untransfected HeLa cells. Pertussis toxin (200 ng/ml) prevented WAY 100635 and spiperone to decrease [S-35]GTP gamma S binding, showing that their effects were mediated by G proteins of the G(i)/G(o) family. In conclusion, the constitutive and stimulated activity of human 5-HT1A receptors expressed in HA7 cells is sodium-dependent, which allowed to confirm the 5-HT1A inverse agonist properties of spiperone, and to show that WAY 100635 is an inverse agonist at 5-HT1A receptors that inhibits basal [S-35]GTP gamma S binding to a lesser extent than spiperone. [S-35]GTP gamma S binding to membranes from HA7 cells under low NaCl conditions appears to be especially suitable to evidence and pharmacologically analyze the inverse agonist properties of 5-HT1A receptor ligands. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 18 条
[1]   Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties [J].
Assie, MB ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) :15-21
[2]   Agonist-independent activation of Gz by the 5-hydroxytryptamine1A receptor co-expressed in Spodoptera frugiperda cells -: Distinguishing inverse agonists from neutral antagonists [J].
Barr, AJ ;
Manning, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :32979-32987
[3]  
COSTA T, 1992, MOL PHARMACOL, V41, P549
[4]  
COSTA T, 1990, MOL PHARMACOL, V37, P383
[5]  
FARGIN A, 1989, J BIOL CHEM, V264, P14848
[6]  
Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
[7]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[8]   Sodium dependency of constitutive activity at 5-HT1D alpha/1D beta receptors [J].
Gray, DW ;
Giles, H ;
Barrett, V ;
Martin, GR .
RECEPTOR CLASSIFICATION: THE INTEGRATION OF OPERATIONAL, STRUCTURAL, AND TRANSDUCTIONAL INFORMATION, 1997, 812 :236-239
[9]  
JAGADEESH G, 1990, J PHARMACOL EXP THER, V252, P1184
[10]   Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors [J].
McLoughlin, DJ ;
Strange, PG .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :347-357